Clearbridge Investments, LLC Viatris Inc Transaction History

Clearbridge Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $716,434 - $1.12 Million	-73,031 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $71,101 - $86,333	-5,881 Reduced 7.45%	73,031 $988,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $56,696 - $64,741	-4,279 Reduced 5.14%	78,912 $1.07 Million
Q2 2021 Aug 13, 2021	BUY	$12.97 - $16.15 $324,755 - $404,379	25,039 Added 43.06%	83,191 $1.19 Million
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $5.58 Million - $7.62 Million	-410,898 Reduced 87.6%	58,152 $812,000
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $6.71 Million - $8.79 Million	469,050 New	469,050 $8.79 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.